Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronectin (fFN) testing and cervical length (CL) improves the prediction of preterm delivery (PTD) within 7 days compared with qualitative fFN and CL. Design Post hoc analysis of frozen fFN samples of a nationwide cohort study. Setting Ten perinatal centres in the Netherlands. Population Symptomatic women between 24 and 34 weeks of gestation. Methods The risk of PTD 500 ng/ml). Multivariable logistic regression showed an increasing risk of PTD in 500 ng/ml: OR 39, 95% CI 9.4-164] and shortening of the CL (OR 0.86 per mm, 95% CI 0.82-0.90). Use of quantitative fFN instead of qualitative fFN resulted in reclassification of 18 (5%) women from high to lo...
OBJECTIVE: To estimate the performance of combining cervical length measurement with fetal fibronect...
Objective: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronect...
Objective To assess whether patient characteristics add to the fetal fibronectin test and cervical l...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
To evaluate whether in symptomatic women, the combination of quantitative fetal fibronectin (fFN) te...
OBJECTIVE: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronect...
Item does not contain fulltextTo evaluate whether in symptomatic women, the combination of quantitat...
\u3cp\u3eObjective: To evaluate whether in symptomatic women, the combination of quantitative fetal ...
OBJECTIVE: To estimate the performance of combining cervical length measurement with fetal fibronect...
OBJECTIVE: To estimate the performance of combining cervical length measurement with fetal fibronect...
OBJECTIVE: To estimate the performance of combining cervical length measurement with fetal fibronect...
OBJECTIVE: To estimate the performance of combining cervical length measurement with fetal fibronect...
Objective: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronect...
Objective To assess whether patient characteristics add to the fetal fibronectin test and cervical l...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
Objective To evaluate whether in symptomatic women, the combination of quantitative fetal fibronecti...
To evaluate whether in symptomatic women, the combination of quantitative fetal fibronectin (fFN) te...
OBJECTIVE: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronect...
Item does not contain fulltextTo evaluate whether in symptomatic women, the combination of quantitat...
\u3cp\u3eObjective: To evaluate whether in symptomatic women, the combination of quantitative fetal ...
OBJECTIVE: To estimate the performance of combining cervical length measurement with fetal fibronect...
OBJECTIVE: To estimate the performance of combining cervical length measurement with fetal fibronect...
OBJECTIVE: To estimate the performance of combining cervical length measurement with fetal fibronect...
OBJECTIVE: To estimate the performance of combining cervical length measurement with fetal fibronect...
Objective: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronect...
Objective To assess whether patient characteristics add to the fetal fibronectin test and cervical l...